Vanguard Fiduciary Trust
XGN icon

Vanguard Fiduciary Trust’s Exagen XGN Stock Holding History

Vanguard Fiduciary Trust’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$505K Buy
108,649
+11,350
+12% +$42.7K ﹤0.01% 3270
2026
Q1 		$292K Buy
+97,299
New +$376K ﹤0.01% 3395

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Vanguard Fiduciary Trust's XGN Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Exagen (XGN) stake by 12% in Q2 2026, buying an estimated $42.7K and bringing the position to 108,649 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #3270.

Vanguard Fiduciary Trust first reported a position in XGN in Q1 2026 and has held it in 2 quarters since. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Vanguard Fiduciary Trust held 108,649 shares of Exagen worth $505K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 11,350 Exagen shares in Q2 2026, an estimated $42.7K.
  • Exagen made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3270 holding.
  • Vanguard Fiduciary Trust first reported a position in Exagen in Q1 2026 and has held it in 2 quarters since.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.